Compare Abbott India with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ALEMBIC LTD - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ALEMBIC LTD ABBOTT INDIA/
ALEMBIC LTD
 
P/E (TTM) x 59.6 51.0 117.0% View Chart
P/BV x 17.6 4.4 400.4% View Chart
Dividend Yield % 0.4 0.2 168.3%  

Financials

 ABBOTT INDIA   ALEMBIC LTD
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
ALEMBIC LTD
Mar-18
ABBOTT INDIA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs8,83472 12,269.6%   
Low Rs5,45834 16,098.8%   
Sales per share (Unadj.) Rs1,731.14.7 36,827.4%  
Earnings per share (Unadj.) Rs211.96.1 3,472.0%  
Cash flow per share (Unadj.) Rs219.96.2 3,520.8%  
Dividends per share (Unadj.) Rs65.000.20 32,500.0%  
Dividend yield (eoy) %0.90.4 240.8%  
Book value per share (Unadj.) Rs945.240.7 2,324.6%  
Shares outstanding (eoy) m21.25267.03 8.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.111.3 36.6%   
Avg P/E ratio x33.78.7 388.7%  
P/CF ratio (eoy) x32.58.5 383.3%  
Price / Book Value ratio x7.61.3 580.5%  
Dividend payout %30.73.3 936.0%   
Avg Mkt Cap Rs m151,84814,139 1,073.9%   
No. of employees `0003.5NA-   
Total wages/salary Rs m4,356207 2,100.2%   
Avg. sales/employee Rs Th10,555.5NM-  
Avg. wages/employee Rs Th1,249.9NM-  
Avg. net profit/employee Rs Th1,292.2NM-  
INCOME DATA
Net Sales Rs m36,7861,255 2,930.7%  
Other income Rs m1,133370 306.0%   
Total revenues Rs m37,9191,625 2,332.9%   
Gross profit Rs m6,047111 5,443.1%  
Depreciation Rs m16938 447.6%   
Interest Rs m232 1,323.5%   
Profit before tax Rs m6,989442 1,581.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,48524 10,376.6%   
Profit after tax Rs m4,5031,630 276.3%  
Gross profit margin %16.48.9 185.7%  
Effective tax rate %35.65.4 656.0%   
Net profit margin %12.2129.8 9.4%  
BALANCE SHEET DATA
Current assets Rs m27,6101,867 1,478.8%   
Current liabilities Rs m8,569591 1,449.4%   
Net working cap to sales %51.8101.6 50.9%  
Current ratio x3.23.2 102.0%  
Inventory Days Days6094 63.9%  
Debtors Days Days2774 37.3%  
Net fixed assets Rs m1,0571,791 59.0%   
Share capital Rs m213534 39.8%   
"Free" reserves Rs m19,87310,324 192.5%   
Net worth Rs m20,08610,858 185.0%   
Long term debt Rs m041 0.0%   
Total assets Rs m29,40911,591 253.7%  
Interest coverage x311.6260.9 119.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.1 1,155.0%   
Return on assets %15.414.1 109.3%  
Return on equity %22.415.0 149.4%  
Return on capital %34.915.2 229.8%  
Exports to sales %01.5 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs mNA263 0.0%   
Fx inflow Rs m36919 1,901.9%   
Fx outflow Rs m4,918264 1,864.3%   
Net fx Rs m-4,549-244 1,861.3%   
CASH FLOW
From Operations Rs m4,991236 2,116.8%  
From Investments Rs m-2,570-224 1,147.3%  
From Financial Activity Rs m-1,428-27 5,368.4%  
Net Cashflow Rs m993-15 -6,711.5%  

Share Holding

Indian Promoters % 0.0 64.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 0.2 3,950.0%  
FIIs % 0.1 9.7 1.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 26.1 65.5%  
Shareholders   18,270 54,701 33.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DIVIS LABORATORIES  WOCKHARDT  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 225 Points Higher; Metal and Banking Stocks Witness Buying(Closing)

Extending gains to the fourth consecutive session, Indian share markets witnessed buying interest throughout the day today and ended higher.

Related Views on News

J.B.CHEMICALS at All Time High; BSE HEALTHCARE Index Down 0.4% (Market Updates)

Aug 11, 2020 | Updated on Aug 11, 2020

J.B.CHEMICALS share price has hit an all time high at Rs 777 (up 5.2%). The BSE HEALTHCARE Index is down by 0.4%. Among the top gainers in the BSE HEALTHCARE Index today are J.B.CHEMICALS (up 5.2%) and ABBOTT INDIA (up 0.4%). The top losers include LUPIN (down 0.2%) and SUN PHARMA (down 0.2%).

TORRENT PHARMA at All Time High; BSE HEALTHCARE Index Up 0.3% (Market Updates)

Aug 11, 2020 | Updated on Aug 11, 2020

TORRENT PHARMA share price has hit an all time high at Rs 3,040 (down 0.1%). The BSE HEALTHCARE Index is up by 0.3%. Among the top gainers in the BSE HEALTHCARE Index today are TORRENT PHARMA (down 0.4%) and ABBOTT INDIA (up 0.4%). The top losers include THYROCARE TECHNOLOGIES and DR. REDDYS LAB .

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver?(Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

Forget the Nifty and Sensex for the Next 1 or 2 Years and Focus on These Stocks(Profit Hunter)

Aug 6, 2020

Stocks from the essential small cap space are likely to be outperformers over the next 1 or 2 years.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 11, 2020 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS